813 related articles for article (PubMed ID: 27036993)
1. Retention in care during the first 3 years of antiretroviral therapy for women in Malawi's option B+ programme: an observational cohort study.
Haas AD; Tenthani L; Msukwa MT; Tal K; Jahn A; Gadabu OJ; Spoerri A; Chimbwandira F; van Oosterhout JJ; Keiser O
Lancet HIV; 2016 Apr; 3(4):e175-82. PubMed ID: 27036993
[TBL] [Abstract][Full Text] [Related]
2. Adherence to Antiretroviral Therapy During and After Pregnancy: Cohort Study on Women Receiving Care in Malawi's Option B+ Program.
Haas AD; Msukwa MT; Egger M; Tenthani L; Tweya H; Jahn A; Gadabu OJ; Tal K; Salazar-Vizcaya L; Estill J; Spoerri A; Phiri N; Chimbwandira F; van Oosterhout JJ; Keiser O
Clin Infect Dis; 2016 Nov; 63(9):1227-1235. PubMed ID: 27461920
[TBL] [Abstract][Full Text] [Related]
3. HIV transmission and retention in care among HIV-exposed children enrolled in Malawi's prevention of mother-to-child transmission programme.
Haas AD; van Oosterhout JJ; Tenthani L; Jahn A; Zwahlen M; Msukwa MT; Davies MA; Tal K; Phiri N; Spoerri A; Chimbwandira F; Egger M; Keiser O
J Int AIDS Soc; 2017 Sep; 20(1):21947. PubMed ID: 28884524
[TBL] [Abstract][Full Text] [Related]
4. Viral Suppression and HIV Drug Resistance at 6 Months Among Women in Malawi's Option B+ Program: Results From the PURE Malawi Study.
Hosseinipour M; Nelson JAE; Trapence C; Rutstein SE; Kasende F; Kayoyo V; Kaunda-Khangamwa B; Compliment K; Stanley C; Cataldo F; van Lettow M; Rosenberg NE; Tweya H; Gugsa S; Sampathkumar V; Schouten E; Eliya M; Chimbwandira F; Chiwaula L; Kapito-Tembo A; Phiri S;
J Acquir Immune Defic Syndr; 2017 Jun; 75 Suppl 2(Suppl 2):S149-S155. PubMed ID: 28498184
[TBL] [Abstract][Full Text] [Related]
5. Retention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women ('Option B+') in Malawi.
Tenthani L; Haas AD; Tweya H; Jahn A; van Oosterhout JJ; Chimbwandira F; Chirwa Z; Ng'ambi W; Bakali A; Phiri S; Myer L; Valeri F; Zwahlen M; Wandeler G; Keiser O
AIDS; 2014 Feb; 28(4):589-598. PubMed ID: 24468999
[TBL] [Abstract][Full Text] [Related]
6. Role of male partner involvement in ART retention and adherence in Malawi's Option B+ program.
Wesevich A; Mtande T; Saidi F; Cromwell E; Tweya H; Hosseinipour MC; Hoffman I; Miller WC; Rosenberg NE
AIDS Care; 2017 Nov; 29(11):1417-1425. PubMed ID: 28355926
[TBL] [Abstract][Full Text] [Related]
7. Loss to follow-up before and after initiation of antiretroviral therapy in HIV facilities in Lilongwe, Malawi.
Tweya H; Oboho IK; Gugsa ST; Phiri S; Rambiki E; Banda R; Mwafilaso J; Munthali C; Gupta S; Bateganya M; Maida A
PLoS One; 2018; 13(1):e0188488. PubMed ID: 29373574
[TBL] [Abstract][Full Text] [Related]
8. Characteristics and outcomes of women initiating ART during pregnancy versus breastfeeding in Option B+ in Malawi.
Landes M; Sodhi S; Matengeni A; Meaney C; van Lettow M; Chan AK; van Oosterhout JJ
BMC Public Health; 2016 Aug; 15():713. PubMed ID: 27487775
[TBL] [Abstract][Full Text] [Related]
9. Towards elimination of mother-to-child transmission of HIV: performance of different models of care for initiating lifelong antiretroviral therapy for pregnant women in Malawi (Option B+).
van Lettow M; Bedell R; Mayuni I; Mateyu G; Landes M; Chan AK; van Schoor V; Beyene T; Harries AD; Chu S; Mganga A; van Oosterhout JJ
J Int AIDS Soc; 2014; 17(1):18994. PubMed ID: 25079437
[TBL] [Abstract][Full Text] [Related]
10. Patterns of HIV Care Clinic Attendance and Adherence to Antiretroviral Therapy Among Pregnant and Breastfeeding Women Living With HIV in the Context of Option B+ in Zimbabwe.
Erlwanger AS; Joseph J; Gotora T; Muzunze B; Orne-Gliemann J; Mukungunugwa S; Farley T; Mangwiro AZ
J Acquir Immune Defic Syndr; 2017 Jun; 75 Suppl 2():S198-S206. PubMed ID: 28498190
[TBL] [Abstract][Full Text] [Related]
11. Ensuring HIV-infected pregnant women start antiretroviral treatment: an operational cohort study from Lilongwe, Malawi.
Weigel R; Hosseinipour MC; Feldacker C; Gareta D; Tweya H; Chiwoko J; Gumulira J; Kalulu M; Mofolo I; Kamanga E; Mwale G; Kadzakumanja A; Jere E; Phiri S
Trop Med Int Health; 2012 Jun; 17(6):751-9. PubMed ID: 22487553
[TBL] [Abstract][Full Text] [Related]
12. Assessing Option B+ retention and infant follow-up in Lilongwe, Malawi.
Hauser BM; Miller WC; Tweya H; Speight C; Mtande T; Phiri S; Ball LM; Hosseinipour MC; Hoffman IF; Rosenberg NE
Int J STD AIDS; 2018 Feb; 29(2):185-194. PubMed ID: 28750577
[TBL] [Abstract][Full Text] [Related]
13. Retention, transfer out and loss to follow-up two years after delivery in a cohort of HIV+ pregnant women in Malawi.
Giuliano M; Liotta G; Andreotti M; Mancinelli S; Buonomo E; Scarcella P; Amici R; Jere H; Sagno JB; Di Gregorio M; Marazzi MC; Vella S; Palombi L
Int J STD AIDS; 2016 May; 27(6):462-8. PubMed ID: 25953961
[TBL] [Abstract][Full Text] [Related]
14. HIV testing uptake and retention in care of HIV-infected pregnant and breastfeeding women initiated on 'Option B+' in rural Zimbabwe.
Dzangare J; Takarinda KC; Harries AD; Tayler-Smith K; Mhangara M; Apollo TM; Mushavi A; Chimwaza A; Sithole N; Magure T; Mpofu A; Dube F; Mugurungi O
Trop Med Int Health; 2016 Feb; 21(2):202-9. PubMed ID: 26555353
[TBL] [Abstract][Full Text] [Related]
15. Understanding factors, outcomes and reasons for loss to follow-up among women in Option B+ PMTCT programme in Lilongwe, Malawi.
Tweya H; Gugsa S; Hosseinipour M; Speight C; Ng'ambi W; Bokosi M; Chikonda J; Chauma A; Khomani P; Phoso M; Mtande T; Phiri S
Trop Med Int Health; 2014 Nov; 19(11):1360-6. PubMed ID: 25087778
[TBL] [Abstract][Full Text] [Related]
16. Impact of Facility- and Community-Based Peer Support Models on Maternal Uptake and Retention in Malawi's Option B+ HIV Prevention of Mother-to-Child Transmission Program: A 3-Arm Cluster Randomized Controlled Trial (PURE Malawi).
Phiri S; Tweya H; van Lettow M; Rosenberg NE; Trapence C; Kapito-Tembo A; Kaunda-Khangamwa B; Kasende F; Kayoyo V; Cataldo F; Stanley C; Gugsa S; Sampathkumar V; Schouten E; Chiwaula L; Eliya M; Chimbwandira F; Hosseinipour MC;
J Acquir Immune Defic Syndr; 2017 Jun; 75 Suppl 2():S140-S148. PubMed ID: 28498183
[TBL] [Abstract][Full Text] [Related]
17. An assessment of option B implementation for the prevention of mother to child transmission in Dschang, Cameroon: results from the DREAM (Drug Resource Enhancement against AIDS and Malnutrition) cohort.
Altan AM; Taafo F; Fopa F; Buonomo E; Marazzi MC; Nielsen-Saines K; Orlando S; Scarcella P; Ciccacci F; Mancinelli S; Lio MM; Palombi L
Pan Afr Med J; 2016; 23():72. PubMed ID: 27217896
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of Option B+ ART in Malawi: few severe maternal toxicity events or infant HIV infections among pregnant women initiating tenofovir/lamivudine/efavirenz.
Harrington BJ; DiPrete BL; Jumbe AN; Ngongondo M; Limarzi L; Wallie SD; Chagomerana MB; Hosseinipour MC;
Trop Med Int Health; 2019 Oct; 24(10):1221-1228. PubMed ID: 31381233
[TBL] [Abstract][Full Text] [Related]
19. HIV-positive pregnant and postpartum women's perspectives about Option B+ in Malawi: a qualitative study.
Katirayi L; Namadingo H; Phiri M; Bobrow EA; Ahimbisibwe A; Berhan AY; Buono N; Moland KM; Tylleskär T
J Int AIDS Soc; 2016; 19(1):20919. PubMed ID: 27312984
[TBL] [Abstract][Full Text] [Related]
20. Timing of pregnancy, postpartum risk of virologic failure and loss to follow-up among HIV-positive women.
Onoya D; Sineke T; Brennan AT; Long L; Fox MP
AIDS; 2017 Jul; 31(11):1593-1602. PubMed ID: 28463877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
